4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-050064
Chief Executive Officer acquired 75,119 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Schenkein David P Chief Executive Officer | 2018-09-05 | Option exercise | +72,619 | $2.34 | $169,928 | 72,619 | D |
| Schenkein David P Chief Executive Officer | 2018-09-05 | Option exercise | +2,500 | $31.64 | $79,100 | 75,119 | D |
| Derivatives | |||||||
| Schenkein David P Chief Executive Officer | 2018-09-05 | Option exercise · Stock option (right to buy) | −72,619 | 0 | D | ||
| Schenkein David P Chief Executive Officer | 2018-09-05 | Option exercise · Stock option (right to buy) | −2,500 | 146,201 | D | ||
Loading xslF345X03/doc4.xml…